Rahimi, Arezou
Vale-Silva, Luis A. http://orcid.org/0000-0002-9658-5335
Fälth Savitski, Maria
Tanevski, Jovan http://orcid.org/0000-0001-7177-1003
Saez-Rodriguez, Julio http://orcid.org/0000-0002-8552-8976
Article History
Received: 7 August 2023
Accepted: 14 May 2024
First Online: 11 June 2024
Competing interests
: A.R. is supported by funding from GSK. J.S.R. reports funding from GSK, Pfizer and Sanofi and fees/honoraria from Travere Therapeutics, Stadapharm, Astex, Pfizer and Grunenthal. The remaining authors declare no competing interests.